NCT04871542View on ClinicalTrials.gov

Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors

RecruitingOBSERVATIONAL
Enrollment

2,062

Participants

Timeline

Start Date

September 13, 2021

Primary Completion Date

March 14, 2028

Study Completion Date

March 14, 2028

Conditions
Malignant Solid Neoplasm
Interventions
PROCEDURE

Biospecimen Collection

Undergo collection of blood sample

OTHER

Questionnaire Administration

Complete questionnaires

Trial Locations (6)

50010

RECRUITING

Mary Greeley Medical Center, Ames

RECRUITING

McFarland Clinic PC - Ames, Ames

50036

RECRUITING

McFarland Clinic PC-Boone, Boone

50129

RECRUITING

McFarland Clinic PC-Jefferson, Jefferson

50158

RECRUITING

McFarland Clinic PC-Marshalltown, Marshalltown

50501

RECRUITING

McFarland Clinic PC-Trinity Cancer Center, Fort Dodge

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

SWOG Cancer Research Network

NETWORK